Level C· Early human research exploring benefitsProspective StudyPubMed

Dextran-based hydrogel with enhanced mechanical performance via covalent and non-covalent cross-linking units carrying adipose-derived stem cells toward vascularized bone tissue engineering.

Cai L., Li J., Quan S., Feng W., Yao J., Yang M.

Prospective Study, published in J Biomed Mater Res A (2019) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Biomed Mater Res A (2019)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
30431233
DOI
10.1002/jbm.a.36580
Citations
15

Abstract (original English)

Hydrogels for biomedical applications were limited toward bone tissue engineering due to the poor mechanical performance. Tough hydrogels with strong and elastic features have received extensive attention, the application of which, however, was limited by their degradation. The present study introduced an approach to enhance mechanical properties of hydrogel while ensuring its degradation. Carboxyl dextran (Dex) was grafting modified by poly (ε-caprolactone) (PCL), sequentially followed by being cross-linked through polyethyleneglycol 400 (PEG400) to yield a gel with covalent cross-linking units in DMSO. The gel was underwent solvent displacement in H 2 O to induce hydrophobic association of PCL to form non-covalent cross-linking units. The tough Dex-g-PCL hydrogel showed maximum strain of Dex-g-PCL hydrogel was 90% ± 6%, with the corresponding stress of 2.7 ± 0.2 MPa, which was significantly enhanced when comparing to dextran hydrogel (maximum strain 65% ± 5%, with the corresponding stress of 0.225 ± 0.06 MPa). Most hydrogel degraded after 12 w in vivo with only a little residues. Adipose-derived stem cells (ASCs) proliferated well after being seeded in hydrogel to form micro-mass at 14 days post-seeding. In vitro and in vivo angiogenesis, as well as in vitro osteogenesis illustrated the potential of the Dex-g-PCL hydrogel carrying ASCs toward vascularized bone tissue engineer

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueBone and BonesCross-Linking ReagentsDextransHumansHydrogelsNeovascularization, PhysiologicPolyestersStem CellsTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.